Sonavi Labs develops advanced medical devices and software rooted in AI and applied to auscultation, aimed at detecting and managing respiratory diseases.

Sonavi Labs

TytoCare provides remote physical exam technology that enables clinicians to conduct medical examinations regardless of the patient's location or condition, for both acute and chronic cases.

TytoCare

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Maxwell Becton

Fairleigh Dickinson

Becton, Dickinson and Company

Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. They are focused on developing new medicines to treat patients with respiratory diseases such as cystic fibrosis, asthma, and COPD, aiming to improve patient quality of life and reduce the frequency of lung infections.

Metric
Company Name	Sonavi Labs	TytoCare	Becton, Dickinson and Company	Enterprise Therapeutics
Symbol			BDX
MSH ID	COM:SONAVILABS	COM:TYTOCARE	COM:BD	COM:ENTERPRISETHERAPEUTICS
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare
Industry	Medical Devices	Digital Health and Telemedicine	Medical - Instruments & Supplies	Biotechnology
Country	US	US	US	GB
Stage	Non Equity Assistance			Series B
Employee Count		232	70K	13
Website	sonavilabs.com	tytocare.com	bd.com	enterprisetherapeutics.com
LinkedIn		tytocare-ltd	bd1	enterprise-therapeutics
Founders

Metric
Market Cap	64.70B
Enterprise Value
Monthly Web Traffic		856
Web Traffic Growth		-0.54
Valuation
Raised Capital		33.06M

Metric
Revenue			20.18B
Revenue (LTM)
Revenue (NTM)
Gross Profit			20.18B
EBITDA			2.42B
Operating Income			2.42B
Net Income			1.73B
EPS			5.96
Diluted EPS			5.93
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.55
Operating Profit Margin			0.12
EBITDA Margin			0.12
Net Profit Margin			0.07
Return on Equity			0.06
Return on Assets			0.03
Return on Capital Employed			0.05

SONA

COM:SONAVILABS

Sonavi Labs

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			54.49
P/B Ratio			2.70
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			3.63
EV Multiple			15.21

Metric
Days Sales Outstanding			42.45
Days Payables Outstanding
Days Inventory Outstanding			105.52
Operating Cycle			151.20
Cash Conversion Cycle			47.37
Asset Turnover			0.37

Metric
Operating Cash Flow			3.84B
Free Cash Flow			3.12B
Cash Flow to Debt			0.21
Operating Cash Flow/Sales			0.20
Free Cash Flow Yield			0.04

Metric
Cash & Equivalents			1.86B
Accounts Receivable
Inventory			3.84B
Goodwill			26.46B
Debt to Capitalization			0.43
Debt to Assets			0.33
Current Ratio			1.08
Quick Ratio			1.36

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.01
R&D to Revenue			0.06
SG&A to Revenue